The Venture Codex Logo

The Venture Codex

Novartis

Forum 1, Novartis Campus, Basel, Basel-Stadt, 4056, Switzerland

Overview

Global healthcare company providing patient solutions.

Founded

1996

Deals ยท 12mo

8

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B

Geographic focus

Switzerland
United Kingdom
United States

Sector focus

Biotechnology
Health Care
Medical
Pharmaceutical
...

Investment portfolio

188rounds
NAMEDATESIZE
Fore Biotherapeutics
Jul 2026Participated
$67 MSeries D
Antares Therapeutics
Jul 2026Led
$105 MOther Equity
Flare Therapeutics
Jun 2026Participated
$85 MSeries C
Sidewinder Therapeutics
Apr 2026Led
$137 MSeries B
EpiBiologics
Jan 2026Participated
$107 MSeries B
FoRx Therapeutics
Dec 2025Participated
$50 MSeries A
Protego Biopharma
Dec 2025Led
$130 MSeries B
Artios Pharma
Nov 2025Participated
$115 MSeries D
NRG Therapeutics
Sep 2025Participated
$67 MSeries B
Octave
Sep 2025Participated
$51 MSeries C
Splice Bio
Jun 2025Participated
$135 MSeries B
Fore Biotherapeutics
May 2025Participated
$38 MSeries D
Fore Biotherapeutics
Jul 2026Participated
$67 MSeries D
Antares Therapeutics
Jul 2026Led
$105 MOther Equity
Flare Therapeutics
Jun 2026Participated
$85 MSeries C
Sidewinder Therapeutics
Apr 2026Led
$137 MSeries B
EpiBiologics
Jan 2026Participated
$107 MSeries B
FoRx Therapeutics
Dec 2025Participated
$50 MSeries A
Protego Biopharma
Dec 2025Led
$130 MSeries B
Artios Pharma
Nov 2025Participated
$115 MSeries D
NRG Therapeutics
Sep 2025Participated
$67 MSeries B
Octave
Sep 2025Participated
$51 MSeries C
Splice Bio
Jun 2025Participated
$135 MSeries B
Fore Biotherapeutics
May 2025Participated
$38 MSeries D
188
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Novartis: 188 funding rounds are recorded in the selected participation categories.All available history.
Novartis: 188 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed40
Series A2234
Series B1446
Series C+535
Other Equity820

Monthly Deal Activity

Novartis: 188 deals are recorded across 233 months.All available history.
Novartis: 188 deals are recorded across 233 months. All available history
MonthDeals
Jun '072
Jul '070
Aug '070
Sep '070
Oct '070
Nov '070
Dec '070
Jan '080
Feb '080
Mar '080
Apr '080
May '080
Jun '080
Jul '080
Aug '080
Sep '080
Oct '080
Nov '080
Dec '080
Jan '090
Feb '090
Mar '090
Apr '090
May '090
Jun '090
Jul '090
Aug '090
Sep '090
Oct '091
Nov '091
Dec '091
Jan '102
Feb '101
Mar '100
Apr '100
May '100
Jun '101
Jul '100
Aug '101
Sep '102
Oct '101
Nov '100
Dec '101
Jan '111
Feb '110
Mar '112
Apr '111
May '110
Jun '110
Jul '111
Aug '111
Sep '111
Oct '110
Nov '110
Dec '110
Jan '120
Feb '120
Mar '120
Apr '120
May '120
Jun '120
Jul '120
Aug '120
Sep '120
Oct '122
Nov '120
Dec '122
Jan '131
Feb '130
Mar '130
Apr '133
May '132
Jun '131
Jul '130
Aug '130
Sep '130
Oct '131
Nov '131
Dec '131
Jan '140
Feb '141
Mar '140
Apr '141
May '142
Jun '140
Jul '140
Aug '141
Sep '140
Oct '145
Nov '142
Dec '141
Jan '151
Feb '151
Mar '151
Apr '154
May '150
Jun '150
Jul '151
Aug '151
Sep '151
Oct '152
Nov '150
Dec '150
Jan '162
Feb '160
Mar '160
Apr '160
May '161
Jun '163
Jul '160
Aug '160
Sep '162
Oct '160
Nov '162
Dec '160
Jan '171
Feb '170
Mar '170
Apr '170
May '173
Jun '172
Jul '173
Aug '171
Sep '171
Oct '170
Nov '172
Dec '171
Jan '183
Feb '181
Mar '180
Apr '182
May '180
Jun '180
Jul '180
Aug '183
Sep '184
Oct '180
Nov '181
Dec '181
Jan '192
Feb '191
Mar '191
Apr '190
May '193
Jun '191
Jul '190
Aug '191
Sep '191
Oct '191
Nov '191
Dec '190
Jan '200
Feb '200
Mar '202
Apr '202
May '200
Jun '200
Jul '200
Aug '204
Sep '202
Oct '201
Nov '202
Dec '205
Jan '211
Feb '210
Mar '212
Apr '210
May '212
Jun '210
Jul '213
Aug '212
Sep '212
Oct '211
Nov '211
Dec '212
Jan '221
Feb '222
Mar '220
Apr '220
May '221
Jun '221
Jul '221
Aug '221
Sep '220
Oct '221
Nov '221
Dec '220
Jan '230
Feb '230
Mar '232
Apr '230
May '230
Jun '232
Jul '231
Aug '231
Sep '230
Oct '231
Nov '230
Dec '230
Jan '243
Feb '240
Mar '241
Apr '240
May '240
Jun '241
Jul '241
Aug '241
Sep '242
Oct '241
Nov '240
Dec '241
Jan '253
Feb '250
Mar '250
Apr '251
May '251
Jun '251
Jul '250
Aug '250
Sep '252
Oct '250
Nov '251
Dec '252
Jan '261
Feb '260
Mar '260
Apr '261
May '260
Jun '261
Jul '262
Aug '260
Sep '260
Oct '260

Sector Breakdown

Novartis: Health & Life Sciences is the largest displayed sector by deal count (183 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Novartis: Health & Life Sciences is the largest displayed sector by deal count (183 deals). All available history
SectorDeals
Health & Life Sciences183
Space & Frontier Tech10
Data, Analytics & IT7
Enterprise Software5
Networks, Cloud & Communication4
Hardware & Robotics2
AI & Machine Learning2
Professional Services2
Developer Tools2
Marketing & Advertising1
Manufacturing1
E-Commerce & Retail1
Transportation & Logistics1

Deal Size Distribution

Novartis: 188 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Novartis: 188 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M4
$5M-$10M11
$10M-$25M45
$25M-$50M46
$50M-$100M58
$100M-$250M22
$250M-$500M2
$500M-$1B0
$1B+0

Deals By Geography

Novartis: United States has the largest recorded deal count among the displayed regions (128 deals).All available history.

Top 6 of 6 regions; European countries are grouped as Europe.

Novartis: United States has the largest recorded deal count among the displayed regions (128 deals). All available history
RegionDeals
United States128
Europe55
Israel2
Australia1
021391
Canada1
Novartis: 20 co-investors are shown, with Johnson & Johnson Innovation sharing 18 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Novartis: 20 co-investors are shown, with Johnson & Johnson Innovation sharing 18 recorded deals. All available history
Co-investorShared deals
Johnson & Johnson Innovation18
OrbiMed18
EQT Life Sciences (LSP)17
RA Capital Management15
Pfizer Ventures14
Forbion13
New Enterprise Associates12
SR One12
Google Ventures11
5AM Ventures10
Alexandria Venture Investments10
M Ventures10
Roche Venture10
Astellas Venture Management9
Cormorant Asset Management9
Lilly Ventures9
Novo Ventures9
Polaris Partners9
SV Health Investors9
Versant Ventures9

Investment Strategy

Novartis: Led accounts for 28% and participating for 72% of round participation.All available history.
Novartis: Led accounts for 28% and participating for 72% of round participation. All available history
CategoryDeals (count)Share (%)
Led5328%
Participating13572%
Novartis: Single-lead accounts for 21% and co-led for 79% of lead dynamics.All available history.
Novartis: Single-lead accounts for 21% and co-led for 79% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1121%
Co-led4279%

Team

Alexander Clavel

Co-Founder

Bruno Villetelle

Global Head of Data & Digital

Darrell White

Consultant

Dejan Arzensek

Senior Manager

Fiona H. Marshall
Janneke van der Kamp

Head Region Europe

Johann Rudolf

Co-Founder

Laura Brass

Managing Director

Michal Silverberg

Managing Director

Michelle Chernock

Therapeutic Area Head for Neuroscience

Mirjam Neelen

Head of Global Learning Design & Learning Sciences

Peggy Carter

Director Regulatory Affairs

Sonja Catrin Fabian

Global Head Talent Management & Leadership, Sandoz